UpdatesGeneral Updates
Honasa Consumer has called off its planned 58% acquisition of Fluence Pharma due to unmet closing conditions.
Honasa Consumer LimitedHONASA · Filed with the exchange
The company reaffirms its commitment to the Nutraceuticals strategy and will explore new opportunities.
No comments yet. Be the first.